SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Pazoo Inc (OTCMKTS:PZOO) announced that it formed a new wholly owned subsidiary named as ‘CannabisKing Distribution LLC.’ It has been formed to serve as the sales and marketing agent for the distribution of its ‘non-controlled’ hemp items throughout the U.S. These items are used by the industry that supports cultivation facilities, dispensaries and infusion companies.

The reason

Through Pazoo’s other subsidiary firms, strong alliances are already being made with a large number of cultivators and other industry linked enterprises. A lot many product support-related firms have taken note of the development and have requested the company to become a sales and distribution entity for them. It is the prime reason behind the formation of CannabisKing.

The management view

David Cunic, the CEO of Pazoo said that they are very delighted and excited with formation of another subsidiary firm. The subsidiary CannabisKing is formed due to demand by existing industry suppliers. The company recorded this demand coming through social media presence and online presence. Also, they were asked for same while the company’s experts attended several events and expositions. A large number of industry suppliers have acknowledged that Pazoo is set to leave the largest footprint throughout the nation. These suppliers intend to get access through Pazoo and its developing relationships.

Opening of lab

In unrelated news, Pazoo Inc (OTCMKTS:PZOO)’s subsidiary firm M & A Associates, LLC in Nevada announced that it hosted a grand inauguration of its Las Vegas, Nevada, Testing Lab on June 3, 2015. The first part of fest was held from 3:30 pm to 7:00PM at the lab in Las Vegas and was an open house for all the people. The second half was scheduled from 6:00PM to 10:00PM.

On Friday’s trading session, the stock price of Pazoo opened higher with gains of more than 7%. The stock had closed in red in previous four trading sessions in the week.